Rome, Italy

Alessandro Sisto


Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 121(Granted Patents)


Company Filing History:


Years Active: 1985-2007

Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Alessandro Sisto

Introduction

Alessandro Sisto is an accomplished inventor based in Rome, Italy, recognized for his significant contributions to the field of pharmaceutical compounds. With a total of 15 patents to his name, he has made remarkable strides in developing compounds that exhibit potential therapeutic activities.

Latest Patents

Among his latest patents are two notable inventions focusing on novel compounds acting as antagonists of tachykinins. The first patent describes linear basic compounds having NK-2 antagonist activity, detailing compounds that are useful as antagonists of tachykinins, specifically neurokinin A. The second patent focuses on tachykinins antagonists, generalizing the formula for these compounds and detailing their preparation and pharmaceutical compositions.

Career Highlights

Alessandro has held positions in prestigious companies such as Eniricerche S.p.a. and Sclavo Spa. His innovative mindset and dedication to research and development have enabled him to significantly contribute to pharmaceutical science. His extensive work has not only furthered his career but also advanced the frontiers of medical treatments.

Collaborations

Throughout his career, Alessandro has collaborated with esteemed colleagues, including Antonio S. Verdini and Antonino Virdia. These collaborations have amplified the impact of his work, fostering a dynamic environment for creativity and innovation.

Conclusion

Alessandro Sisto exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through numerous patents and collaborations reflect a commitment to the advancement of medical science. As he continues to refine and expand his work, Alessandro remains a significant figure in the realm of pharmaceutical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…